Skip to main content

Advertisement

Log in

Exercise Training for Cancer Survivors

  • Cardio-oncology (MG Fradley, Section Editor)
  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

Cardiovascular diseases are a common cause of morbidity and mortality in cancer survivors. Furthermore, some cancer therapies are now being increasingly recognized to have negative cardiovascular effects, or cardiotoxicity. Exercise therapy has been found to improve cardiorespiratory fitness in patients with cancer as well as attenuate the cardiotoxic effects of cancer therapy. It is the centerpiece for cardiac and pulmonary rehabilitation programs. It is also an important component in cardio-oncology rehabilitation. Exercise is generally safe, and its benefit is observed when started as soon as the diagnosis of cancer and throughout cancer survivorship.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Hooning MJ, Botma A, Aleman BM, Baaijens MH, Bartelink H, Klijn JG, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 2007;99(5):365–75. https://doi.org/10.1093/jnci/djk064.

    Article  PubMed  Google Scholar 

  2. Baker KS, Ness KK, Steinberger J, Carter A, Francisco L, Burns LJ, et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood. 2007;109(4):1765–72. https://doi.org/10.1182/blood-2006-05-022335.

    Article  CAS  PubMed  Google Scholar 

  3. Lakoski SG, Barlow CE, Koelwyn GJ, Hornsby WE, Hernandez J, Defina LF, et al. The influence of adjuvant therapy on cardiorespiratory fitness in early-stage breast cancer seven years after diagnosis: the Cooper Center Longitudinal Study. Breast Cancer Res Treat. 2013;138(3):909–16. https://doi.org/10.1007/s10549-013-2478-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Jones LW, Hornsby WE, Goetzinger A, Forbes LM, Sherrard EL, Quist M, et al. Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer. Lung Cancer. 2012;76(2):248–52. https://doi.org/10.1016/j.lungcan.2011.10.009.

    Article  PubMed  Google Scholar 

  5. Jarden M, Hovgaard D, Boesen E, Quist M, Adamsen L. Pilot study of a multimodal intervention: mixed-type exercise and psychoeducation in patients undergoing allogeneic stem cell transplantation. Bone Marrow Transplant. 2007;40(8):793–800. https://doi.org/10.1038/sj.bmt.1705807.

    Article  CAS  PubMed  Google Scholar 

  6. Jones LW, Courneya KS, Mackey JR, Muss HB, Pituskin EN, Scott JM, et al. Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum. J Clin Oncol. 2012;30(20):2530–7. https://doi.org/10.1200/JCO.2011.39.9014.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Adams MJ, Lipsitz SR, Colan SD, Tarbell NJ, Treves ST, Diller L, et al. Cardiovascular status in long-term survivors of Hodgkin’s disease treated with chest radiotherapy. J Clin Oncol. 2004;22(15):3139–48. https://doi.org/10.1200/JCO.2004.09.109.

    Article  PubMed  Google Scholar 

  8. Peel AB, Barlow CE, Leonard D, DeFina LF, Jones LW, Lakoski SG. Cardiorespiratory fitness in survivors of cervical, endometrial, and ovarian cancers: the Cooper Center Longitudinal Study. Gynecol Oncol. 2015;138(2):394–7. https://doi.org/10.1016/j.ygyno.2015.05.027.

    Article  PubMed  Google Scholar 

  9. Miller AM, Lopez-Mitnik G, Somarriba G, Lipsitz SR, Hinkle AS, Constine LS, et al. Exercise capacity in long-term survivors of pediatric cancer: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study. Pediatr Blood Cancer. 2013;60(4):663–8. https://doi.org/10.1002/pbc.24410.

    Article  PubMed  Google Scholar 

  10. Tu H, Wen CP, Tsai SP, Chow WH, Wen C, Ye Y, et al. Cancer risk associated with chronic diseases and disease markers: prospective cohort study. BMJ. 2018;360:k134. https://doi.org/10.1136/bmj.k134.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Gilchrist SC, Barac A, Ades PA, Alfano CM, Franklin BA, Jones LW, et al. Cardio-oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: a scientific statement from the American Heart Association. Circulation. 2019;139(21):e997–e1012. https://doi.org/10.1161/CIR.0000000000000679.

    Article  PubMed  Google Scholar 

  12. Physical activity guidelines for Americans. Okla Nurse. 2008;53(4):25.

  13. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–52. https://doi.org/10.1016/S0140-6736(04)17018-9.

    Article  PubMed  Google Scholar 

  14. Friedenreich CM. Physical activity and breast cancer: review of the epidemiologic evidence and biologic mechanisms. Recent Results Cancer Res. 2011;188:125–39. https://doi.org/10.1007/978-3-642-10,858-7_11.

    Article  CAS  PubMed  Google Scholar 

  15. Monninkhof EM, Velthuis MJ, Peeters PH, Twisk JW, Schuit AJ. Effect of exercise on postmenopausal sex hormone levels and role of body fat: a randomized controlled trial. J Clin Oncol. 2009;27(27):4492–9. https://doi.org/10.1200/JCO.2008.19.7459.

    Article  CAS  PubMed  Google Scholar 

  16. McGowan JV, Chung R, Maulik A, Piotrowska I, Walker JM, Yellon DM. Anthracycline chemotherapy and cardiotoxicity. Cardiovasc Drugs Ther. 2017;31(1):63–75. https://doi.org/10.1007/s10557-016-6711-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Lenneman CG, Sawyer DB. Cardio-oncology: an update on cardiotoxicity of cancer-related treatment. Circ Res. 2016;118(6):1008–20. https://doi.org/10.1161/CIRCRESAHA.115.303633.

    Article  CAS  PubMed  Google Scholar 

  18. Childs AC, Phaneuf SL, Dirks AJ, Phillips T, Leeuwenburgh C. Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. Cancer Res. 2002;62(16):4592–8.

    CAS  PubMed  Google Scholar 

  19. Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer. 2003;97(11):2869–79. https://doi.org/10.1002/cncr.11407.

    Article  CAS  PubMed  Google Scholar 

  20. van Nimwegen FA, Schaapveld M, Janus CP, Krol AD, Petersen EJ, Raemaekers JM, et al. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk. JAMA Intern Med. 2015;175(6):1007–17. https://doi.org/10.1001/jamainternmed.2015.1180.

    Article  PubMed  Google Scholar 

  21. Armenian SH, Hudson MM, Mulder RL, Chen MH, Constine LS, Dwyer M, et al. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2015;16(3):e123–36. https://doi.org/10.1016/S1470-2045(14)70409-7.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Ewer MS, Vooletich MT, Durand JB, Woods ML, Davis JR, Valero V, et al. Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment. J Clin Oncol. 2005;23(31):7820–6. https://doi.org/10.1200/JCO.2005.13.300.

    Article  CAS  PubMed  Google Scholar 

  23. Jawa Z, Perez RM, Garlie L, Singh M, Qamar R, Khandheria BK, et al. Risk factors of trastuzumab-induced cardiotoxicity in breast cancer: a meta-analysis. Medicine (Baltimore). 2016;95(44):e5195. https://doi.org/10.1097/MD.0000000000005195.

    Article  CAS  Google Scholar 

  24. Herrmann J, Lerman A, Sandhu NP, Villarraga HR, Mulvagh SL, Kohli M. Evaluation and management of patients with heart disease and cancer: cardio-oncology. Mayo Clin Proc. 2014;89(9):1287–306. https://doi.org/10.1016/j.mayocp.2014.05.013.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Herrmann J, Lerman A. An update on cardio-oncology. Trends Cardiovasc Med. 2014;24(7):285–95. https://doi.org/10.1016/j.tcm.2014.07.003.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Abd El-Gawad HM, El-Sawalhi MM. Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine. J Biochem Mol Toxicol. 2004;18(2):69–77. https://doi.org/10.1002/jbt.20013.

    Article  CAS  PubMed  Google Scholar 

  27. Wallace KB. Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis. Cardiovasc Toxicol. 2007;7(2):101–7. https://doi.org/10.1007/s12012-007-0008-2.

    Article  CAS  PubMed  Google Scholar 

  28. Santos DL, Moreno AJ, Leino RL, Froberg MK, Wallace KB. Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy. Toxicol Appl Pharmacol. 2002;185(3):218–27. https://doi.org/10.1006/taap.2002.9532.

    Article  CAS  PubMed  Google Scholar 

  29. Ascensao A, Lumini-Oliveira J, Machado NG, Ferreira RM, Goncalves IO, Moreira AC, et al. Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats. Clin Sci (Lond). 2011;120(1):37–49. https://doi.org/10.1042/CS20100254.

    Article  CAS  Google Scholar 

  30. Wonders KY, Hydock DS, Schneider CM, Hayward R. Acute exercise protects against doxorubicin cardiotoxicity. Integr Cancer Ther. 2008;7(3):147–54. https://doi.org/10.1177/1534735408322848.

    Article  CAS  PubMed  Google Scholar 

  31. Ascensao A, Magalhaes J, Soares J, Ferreira R, Neuparth M, Marques F, et al. Endurance training attenuates doxorubicin-induced cardiac oxidative damage in mice. Int J Cardiol. 2005;100(3):451–60. https://doi.org/10.1016/j.ijcard.2004.11.004.

    Article  PubMed  Google Scholar 

  32. Chicco AJ, Schneider CM, Hayward R. Exercise training attenuates acute doxorubicin-induced cardiac dysfunction. J Cardiovasc Pharmacol. 2006;47(2):182–9. https://doi.org/10.1097/01.fjc.0000199682.43448.2d.

    Article  CAS  PubMed  Google Scholar 

  33. Marques-Aleixo I, Santos-Alves E, Mariani D, Rizo-Roca D, Padrao AI, Rocha-Rodrigues S, et al. Physical exercise prior and during treatment reduces sub-chronic doxorubicin-induced mitochondrial toxicity and oxidative stress. Mitochondrion. 2015;20:22–33. https://doi.org/10.1016/j.mito.2014.10.008.

    Article  CAS  PubMed  Google Scholar 

  34. de Paleville DT, Topp RV, Swank AM. Effects of aerobic training prior to and during chemotherapy in a breast cancer patient: a case study. J Strength Cond Res. 2007;21(2):635–7. https://doi.org/10.1519/R-19735.1.

    Article  PubMed  Google Scholar 

  35. Gillis C, Li C, Lee L, Awasthi R, Augustin B, Gamsa A, et al. Prehabilitation versus rehabilitation: a randomized control trial in patients undergoing colorectal resection for cancer. Anesthesiology. 2014;121(5):937–47. https://doi.org/10.1097/ALN.0000000000000393.

    Article  PubMed  Google Scholar 

  36. MacVicar M, Winningham M, Nickel J. Effects of aerobic interval training on cancer patients’ functional capacity. Nurs Res. 1989;38:348–51.

    Article  CAS  Google Scholar 

  37. van Waart H, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, et al. Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES randomized clinical trial. J Clin Oncol. 2015;33(17):1918–27. https://doi.org/10.1200/JCO.2014.59.1081.

    Article  CAS  PubMed  Google Scholar 

  38. McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ. 2006;175(1):34–41. https://doi.org/10.1503/cmaj.051073.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Wengstrom Y, Bolam KA, Mijwel S, Sundberg CJ, Backman M, Browall M, et al. Optitrain: a randomised controlled exercise trial for women with breast cancer undergoing chemotherapy. BMC Cancer. 2017;17(1):100. https://doi.org/10.1186/s12885-017-3079-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Bolam KA, Mijwel S, Rundqvist H, Wengstrom Y. Two-year follow-up of the OptiTrain randomised controlled exercise trial. Breast Cancer Res Treat. 2019;175(3):637–48. https://doi.org/10.1007/s10549-019-05204-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Jones LW, Fels DR, West M, Allen JD, Broadwater G, Barry WT, et al. Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy. Cancer Prev Res (Phila). 2013;6(9):925–37. https://doi.org/10.1158/1940-6207.CAPR-12-0416.

    Article  CAS  Google Scholar 

  42. Segal RJ, Reid RD, Courneya KS, Sigal RJ, Kenny GP, Prud’Homme DG, et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol. 2009;27(3):344–51. https://doi.org/10.1200/JCO.2007.15.4963.

    Article  PubMed  Google Scholar 

  43. Courneya KS, Sellar CM, Stevinson C, McNeely ML, Peddle CJ, Friedenreich CM, et al. Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J Clin Oncol. 2009;27(27):4605–12. https://doi.org/10.1200/JCO.2008.20.0634.

    Article  PubMed  Google Scholar 

  44. Jones LW, Liang Y, Pituskin EN, Battaglini CL, Scott JM, Hornsby WE, et al. Effect of exercise training on peak oxygen consumption in patients with cancer: a meta-analysis. Oncologist. 2011;16(1):112–20. https://doi.org/10.1634/theoncologist.2010-0197.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Scott JM, Zabor EC, Schwitzer E, Koelwyn GJ, Adams SC, Nilsen TS, et al. Efficacy of exercise therapy on cardiorespiratory fitness in patients with cancer: a systematic review and meta-analysis. J Clin Oncol. 2018;36(22):2297–305. https://doi.org/10.1200/JCO.2017.77.5809.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Haykowsky MJ, Mackey JR, Thompson RB, Jones LW, Paterson DI. Adjuvant trastuzumab induces ventricular remodeling despite aerobic exercise training. Clin Cancer Res. 2009;15(15):4963–7. https://doi.org/10.1158/1078-0432.CCR-09-0628.

    Article  CAS  PubMed  Google Scholar 

  47. Jones LW, Liu Q, Armstrong GT, Ness KK, Yasui Y, Devine K, et al. Exercise and risk of major cardiovascular events in adult survivors of childhood hodgkin lymphoma: a report from the childhood cancer survivor study. J Clin Oncol. 2014;32(32):3643–50. https://doi.org/10.1200/JCO.2014.56.7511.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Jones LW, Habel LA, Weltzien E, Castillo A, Gupta D, Kroenke CH, et al. Exercise and risk of cardiovascular events in women with nonmetastatic breast cancer. J Clin Oncol. 2016;34(23):2743–9. https://doi.org/10.1200/JCO.2015.65.6603.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Courneya KS, Mackey JR, Bell GJ, Jones LW, Field CJ, Fairey AS. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol. 2003;21(9):1660–8. https://doi.org/10.1200/JCO.2003.04.093.

    Article  PubMed  Google Scholar 

  50. Rogers LQ, Courneya KS, Anton PM, Hopkins-Price P, Verhulst S, Vicari SK, et al. Effects of the BEAT cancer physical activity behavior change intervention on physical activity, aerobic fitness, and quality of life in breast cancer survivors: a multicenter randomized controlled trial. Breast Cancer Res Treat. 2015;149(1):109–19. https://doi.org/10.1007/s10549-014-3216-z.

    Article  PubMed  Google Scholar 

  51. Pinto BM, Papandonatos GD, Goldstein MG, Marcus BH, Farrell N. Home-based physical activity intervention for colorectal cancer survivors. Psychooncology. 2013;22(1):54–64. https://doi.org/10.1002/pon.2047.

    Article  PubMed  Google Scholar 

  52. Adams SC, DeLorey DS, Davenport MH, Stickland MK, Fairey AS, North S, et al. Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors: a phase 2 randomized controlled trial. Cancer. 2017;123(20):4057–65. https://doi.org/10.1002/cncr.30859.

    Article  PubMed  Google Scholar 

  53. Jarvela LS, Saraste M, Niinikoski H, Hannukainen JC, Heinonen OJ, Lahteenmaki PM, et al. Home-based exercise training improves left ventricle diastolic function in survivors of childhood ALL: a Tissue Doppler and Velocity Vector Imaging Study. Pediatr Blood Cancer. 2016;63(9):1629–35. https://doi.org/10.1002/pbc.26051.

    Article  PubMed  Google Scholar 

  54. Scott JM, Iyengar NM, Nilsen TS, Michalski M, Thomas SM, Herndon J 2nd, et al. Feasibility, safety, and efficacy of aerobic training in pretreated patients with metastatic breast cancer: a randomized controlled trial. Cancer. 2018;124(12):2552–60. https://doi.org/10.1002/cncr.31368.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Jones LW, Douglas PS, Khouri MG, Mackey JR, Wojdyla D, Kraus WE, et al. Safety and efficacy of aerobic training in patients with cancer who have heart failure: an analysis of the HF-ACTION randomized trial. J Clin Oncol. 2014;32(23):2496–502. https://doi.org/10.1200/JCO.2013.53.5724.

    Article  PubMed  PubMed Central  Google Scholar 

  56. O’Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301(14):1439–50. https://doi.org/10.1001/jama.2009.454.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Blanchard CM, Courneya KS, Stein K. American Cancer Society’s SCS, II. Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society’s SCS-II. J Clin Oncol. 2008;26(13):2198–204. https://doi.org/10.1200/JCO.2007.14.6217.

    Article  PubMed  Google Scholar 

  58. Scott JM, Jones LW, Hornsby WE, Koelwyn GJ, Khouri MG, Joy AA, et al. Cancer therapy-induced autonomic dysfunction in early breast cancer: implications for aerobic exercise training. Int J Cardiol. 2014;171(2):e50–1. https://doi.org/10.1016/j.ijcard.2013.11.113.

    Article  PubMed  Google Scholar 

  59. Klijn P, van Keimpema A, Legemaat M, Gosselink R, van Stel H. Nonlinear exercise training in advanced chronic obstructive pulmonary disease is superior to traditional exercise training. A randomized trial. Am J Respir Crit Care Med. 2013;188(2):193–200. https://doi.org/10.1164/rccm.201210-1829OC.

    Article  PubMed  Google Scholar 

  60. Irwin ML, Cartmel B, Harrigan M, Li F, Sanft T, Shockro L, et al. Effect of the LIVESTRONG at the YMCA exercise program on physical activity, fitness, quality of life, and fatigue in cancer survivors. Cancer. 2017;123(7):1249–58. https://doi.org/10.1002/cncr.30456.

    Article  PubMed  Google Scholar 

  61. Santa Mina D, Petrella A, Currie KL, Bietola K, Alibhai SM, Trachtenberg J, et al. Enablers and barriers in delivery of a cancer exercise program: the Canadian experience. Curr Oncol. 2015;22(6):374–84. https://doi.org/10.3747/co.22.2650.

    Article  CAS  PubMed  Google Scholar 

  62. Thomson CA, Crane TE, Miller A, Garcia DO, Basen-Engquist K, Alberts DS. A randomized trial of diet and physical activity in women treated for stage II-IV ovarian cancer: Rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIVES): an NRG Oncology/Gynecologic Oncology Group (GOG-225) Study. Contemp Clin Trials. 2016;49:181–9. https://doi.org/10.1016/j.cct.2016.07.005.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Courneya KS, Booth CM, Gill S, O’Brien P, Vardy J, Friedenreich CM, et al. The Colon Health and Life-Long Exercise Change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials Group. Curr Oncol. 2008;15(6):279–85. https://doi.org/10.3747/co.v15i6.378.

    Article  CAS  PubMed  Google Scholar 

  64. Newton RU, Kenfield SA, Hart NH, Chan JM, Courneya KS, Catto J, et al. Intense exercise for survival among men with metastatic castrate-resistant prostate cancer (INTERVAL-GAP4): a multicentre, randomised, controlled phase III study protocol. BMJ Open. 2018;8(5):e022899. https://doi.org/10.1136/bmjopen-2018-022899.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Pituskin E, Haykowsky M, McNeely M, Mackey J, Chua N, Paterson I. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN). BMC Cancer. 2016;16(1):733. https://doi.org/10.1186/s12885-016-2761-8.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Margot K. Davis MD.

Ethics declarations

Conflict of interest

Calvin K.W. Tong, Benny Lau and Margot Davis declare that they have no conflict of interest.

Human and animal rights and informed consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical collection on Cardio-oncology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tong, C.K., Lau, B. & Davis, M.K. Exercise Training for Cancer Survivors. Curr. Treat. Options in Oncol. 21, 53 (2020). https://doi.org/10.1007/s11864-020-00752-w

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11864-020-00752-w

Keywords

Navigation